Solventum plans software separation to become ‘true medtech company’

Solventum plans software separation to become ‘true medtech company’ is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Nick Paul Taylor · 2026-08-06

The software business needs “a different investment level” to quickly realize its potential, Solventum’s CEO said.

Source: MedTech Dive